These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 21708485)

  • 61. Genetics and pulmonary medicine. 5. Genetics of drug resistant tuberculosis.
    Telenti A
    Thorax; 1998 Sep; 53(9):793-7. PubMed ID: 10319064
    [No Abstract]   [Full Text] [Related]  

  • 62. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
    Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
    Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():80-1. PubMed ID: 27128620
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.
    Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Dusthackeer VNA; Rode HB
    Eur J Med Chem; 2019 Feb; 164():665-677. PubMed ID: 30654238
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Resistance to antimicrobial agents in Mycobacterium tuberculosis.
    Pfyffer GE
    Acta Cient Venez; 2001; 52 Suppl 1():36-9. PubMed ID: 11899703
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Revisiting the β-Lactams for Tuberculosis Therapy with a Compound-Compound Synthetic Lethality Approach.
    Xiao S; Guo H; Weiner WS; Maddox C; Mao C; Gunosewoyo H; Pelly S; White EL; Rasmussen L; Schoenen FJ; Aubé J; Bishai WR; Lun S
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427291
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tuberculosis susceptibility--implications for drug development and therapy.
    Snell NJ
    Expert Opin Pharmacother; 2003 Sep; 4(9):1455-60. PubMed ID: 12943474
    [No Abstract]   [Full Text] [Related]  

  • 67. Drug-resistant tuberculosis: what do we do now?
    Telenti A; Iseman M
    Drugs; 2000 Feb; 59(2):171-9. PubMed ID: 10730543
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rediscovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in Mycobacterium tuberculosis.
    Wang H; Xu M; Engelhart CA; Zhang X; Yan B; Pan M; Xu Y; Fan S; Liu R; Xu L; Hua L; Schnappinger D; Chen S
    J Biol Chem; 2021; 296():100257. PubMed ID: 33837735
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular characterization of ofloxacin-resistant Mycobacterium tuberculosis strains from Russia.
    Mokrousov I; Otten T; Manicheva O; Potapova Y; Vishnevsky B; Narvskaya O; Rastogi N
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2937-9. PubMed ID: 18559646
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Revisiting Activation of and Mechanism of Resistance to Compound IQG-607 in Mycobacterium tuberculosis.
    Abbadi BL; Villela AD; Rodrigues-Junior VS; Subtil FT; Dalberto PF; Pinheiro APS; Santos DS; Machado P; Basso LA; Bizarro CV
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158273
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fluoroquinolone resistance in multidrug-resistant
    Che Y; Song Q; Yang T; Ping G; Yu M
    Eur Respir J; 2017 Dec; 50(6):. PubMed ID: 29217603
    [No Abstract]   [Full Text] [Related]  

  • 72. [Resistant tuberculosis: a molecular review].
    Rossetti ML; Valim AR; Silva MS; Rodrigues VS
    Rev Saude Publica; 2002 Aug; 36(4):525-32. PubMed ID: 12364929
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis.
    Urban M; Šlachtová V; Brulíková L
    Eur J Med Chem; 2021 Feb; 212():113139. PubMed ID: 33422979
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy.
    Vilchèze C; Copeland J; Keiser TL; Weisbrod T; Washington J; Jain P; Malek A; Weinrick B; Jacobs WR
    mBio; 2018 May; 9(3):. PubMed ID: 29844114
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Overcoming drug resistance in TB: an update.
    Consalvi S; Poce G; Scarpecci C; Biava M
    Future Microbiol; 2020 Nov; 15():1607-1609. PubMed ID: 33215545
    [No Abstract]   [Full Text] [Related]  

  • 76. Ring-substituted quinolines as potential anti-tuberculosis agents.
    Vangapandu S; Jain M; Jain R; Kaur S; Singh PP
    Bioorg Med Chem; 2004 May; 12(10):2501-8. PubMed ID: 15110831
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Target Discovery for New Antitubercular Drugs Using a Large Dataset of Growth Inhibitors from PubChem.
    Goldman RC
    Infect Disord Drug Targets; 2020; 20(3):352-366. PubMed ID: 30520384
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genotype analysis of ofloxacin-resistant multidrug-resistant
    Gupta A; Sinha P; Rathod S; Shanmugam SK; Uma Devi KR; Anupurba S; Nema V
    Indian J Med Res; 2020 Apr; 151(4):361-370. PubMed ID: 32461400
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mutations associated with in vitro resistance to bedaquiline in Mycobacterium tuberculosis isolates in Australia.
    Martinez E; Hennessy D; Jelfs P; Crighton T; Chen SC; Sintchenko V
    Tuberculosis (Edinb); 2018 Jul; 111():31-34. PubMed ID: 30029911
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pyrazinamide Resistance among Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Myanmar.
    Aung WW; Ei PW; Nyunt WW; Htwe MM; Win SM; Aye KT; Mon AS; Aung ST; Chang CL; Lee JS
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263056
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.